ArticlePDF Available

Orthotopic heart transplantation with bicaval anastomosis

Authors:
Brief
Communication
Orthotopic
Heart
Transplantation
with
Bicaval
Anastomosis
Antonino
M.
Grande,
MD
Massimo
Pozzoli,
MD
Egidio
Traversi,
MD
Luigi
Martinelli,
MD
Gaetano
Minzioni,
MD
Andrea
M.
D'Armini,
MD
Mauro
Rinaldi,
MD
Mario
Vigan6,
MD
Key
words:
Automated
boundary
detection;
echocar-
diography,
two-dimensional;
heart
transplantation
From:
Divisione
di
Cardio-
chirurgia
(Drs.
Grande,
Martinelli,
Minzioni,
D'Armini,
Rinaldi,
and
Vigan6),
Istituto
di
Chirurgia
Generale
e
dei
Trapianti
d'Organo,
IRCCS
Policlinico
San
Matteo,
Universita
degli
Studi
Pavia,
27100
Pavia,
Italy;
and
Divisione
Cardi-
ologia
(Drs.
Pozzoli
and
Traversi),
Fondazione
Salvatore
Maugeri,
IRCCS
Centro
Medico
Montescano,
27040
Pavia,
Italy
Address
for
reprints:
Antonino
M.
Grande,
MD,
Divisione
di
Cardiochirurgia,
Istituto
di
Chirurgia
Generale
e
dei
Trapianti
d'Organo,
IRCCS
Policlinico
San
Matteo,
Piazzale
Golgi
2,
27100
Pavia,
Italy
A
t
our
institution,
437
heart
transplantations
have
been
performed
since
November
1985.
In
1995,
we
began
a
randomized
study,
performing
heart
transplantation
using
the
standard
technique
in
38
patients
and
a
bicaval
technique
in
35
patients.
In
this
preliminary
report,
we
present
the
bicaval
technique
as
an
alternative
method
of
orthotopic
cardiac
transplantation.
We
be-
lieve
this
to
be
superior
to
the
standard
technique,
because
the
bicaval
operation
better
preserves
the
right
and
left
atrial
anatomy
(Fig.
1).
Surgical
Technique.
In
the
recipient,
the
aorta
is
cannulated
near
the
base
of
the
brachiocephalic
trunk;
venous
cannulation
is
performed
in
both
venae
cavae.
The
right
atrium
is
completely
resected,
leaving
an
atrial
cuff
at
the
juncture
of
the
superior
and
inferior
venae
cavae.
The
donor
heart
is
excised
with
an
intact
right
atrium
and
a
long
segment
of
the
superior
vena
cava.
The
donor
left
atrium
is
sutured
to
the
stump
of
the
4
pulmonary
veins
in
the
recipient
with
continuous
3-0
Prolene
suture
(Ethicon,
Inc.;
Somerville,
NJ),
by
the
standard
technique.
The
superior
and
inferior
venae
cavae
are
sutured
to
the
recipient
atrial
cuff
with
4-0
Prolene
suture.
The
great
arteries
are
anastomosed
in
the
usual
fashion.
Echocardiographic
Results.
In
Figures
2
and
3,
we
present
postoperative,
api-
cal,
4-chambered,
2-dimensional
echocardiographic
views
with
automated
bound-
ary
detection
in
2
orthotopic
heart
transplant
patients
(patient
A,
standard
technique;
patient
B,
bicaval
technique).
The
areas
of
interest
are
drawn
around
the
right
and
left
atria;
the
corresponding
time/volume
curves
of
the
atria,
also
made
by
the
automated
boundary
detection
system,
are
displayed
beneath
each
echocardiographic
scan.
The
3
phases
of
atrial
function
are
shown
by
the
time/
Fig.
1
Orthotopic
heart
transplantation:
A)
standard
technique;
B)
bicaval
technique.
310
Orthotopic
Heart
Transplantation
Volume
Z3,
Ntimber
4,
1996
Fig.
2
Automated
boundary
detection
of
the
right
atrium:
Fig.
3
Automated
boundary
detection
of
the
left
atrium:
A)
standard;
B)
bicaval.
The
3
phases
of
atrial
function
are
A)
standard;
B)
bicaval.
As
in
Figure
2,
the
3
phases
of
atrial
shown
by
the
time/volume
curves.
Note
that,
in
comparison
function
are
shown
by
the
time/volume
curves.
Note
again
with
patient
A,
the
atrial
volume
is
lower
in
patient
B.
(The
that,
in
comparison
with
patient
A,
the
atrial
volume
is
lower
scale
is
larger
in
(Al.)
in
patient
B.
(The
scale
is
larger
in
[Al.)
R
=
reservoir;
C
=
passive
conduit;
P
=
active
pump
function
R
=
reservoir;
C
=
passive
conduit;
P
=
active
pump
function
volume
curves:
R
=
reservoir,
C
=
passive
conduit,
and
P
=
active
pump
function.
In
the
patient
who
has
undergone
the
bicaval
technique,
both
the
right
(Fig.
2B)
and
the
left
(Fig.
3B)
atrial
volumes
are
remarkably
smaller
and
the
relative
volume
changes
for
each
phase
are
much
greater
than
those
in
the
other
patient
(Fig.
2A
and
3A),
indicating
better
glob-
al
function
and
more
active
pump
function
as
a
re-
sult
of
bicaval
anastomosis.
We
conclude
that
maintaining
the
integrity
of
both
atria
by
the
bicaval
technique
improves
the
hemo-
dynamic
performance
in
orthotopic
heart
transplan-
tation
patients.
Orthotopic
Heart
Transplantation
311
Te-xas
Heart
Instituteiournal
Article
Full-text available
The cohort of long-term survivors of heart transplant is expanding, and the assessment of these patients requires specific knowledge of the surgical techniques employed to implant the donor heart, the physiology of the transplanted heart, complications of invasive tests routinely performed to detect graft rejection (GR), and the specific pathologies that may affect the transplanted heart. A joint EACVI/Brazilian cardio-vascular imaging writing group committee has prepared these recommendations to provide a practical guide to echocardiographers involved in the follow-up of heart transplant patients and a framework for standardized and efficient use of cardiovascular imaging after heart transplant. Since the transplanted heart is smaller than the recipient's dilated heart, the former is usually located more medially in the mediastinum and tends to be rotated clockwise. Therefore, standard views with conventional two-dimensional (2D) echocardiography are often difficult to obtain generating a large variability from patient to patient. Therefore, in echocardiography laboratories equipped with three-dimensional echocardiography (3DE) scanners and specific expertise with the technique, 3DE may be a suitable alternative to conventional 2D echocar-diography to assess the size and the function of cardiac chambers. 3DE measurement of left (LV) and right ventricular (RV) size and function are more accurate and reproducible than conventional 2D calculations. However, clinicians should be aware that cardiac chamber volumes obtained with 3DE cannot be compared with those obtained with 2D echocardiography. To assess cardiac chamber morphology and function during follow-up studies, it is recommended to obtain a comprehensive echocardiographic study at 6 months from the cardiac transplantation as a baseline and make a careful quantitation of cardiac chamber size, RV systolic function, both systolic and diastolic parameters of LV function, and pulmonary artery pressure. Subsequent echocardiographic studies should be interpreted in comparison with the data obtained from the 6-month study. An echocardiographic study, which shows no change from the baseline study, has a high negative predictive value for GR. There is no single systolic or diastolic parameter that can be reliably used to diagnose GR. However, in case several parameters are abnormal, the likelihood of GR increases. When an abnormality is detected, careful revision of images of the present and baseline study (side-by-side) is highly recommended. Global longitudinal strain (GLS) is a suitable parameter to diagnose subclinical allograft dysfunction, regardless of aetiology, by comparing the changes occurring during serial evaluations. Evaluation of GLS could be used in association with endomyocardial biopsy (EMB) to characterize and monitor an acute GR or global dysfunction episode. RV size and function at baseline should be assessed using several parameters, which do not exclusively evaluate longitudinal function. At follow-up echocardiogram, all these parameters should be compared with the baseline values. 3DE may provide a more accurate and comprehensive assessment of RV size and function. Moreover, due to the
Article
We compared orthotopic heart transplantation (HT) by bicaval technique with the standard technique. Between January 1995 and December 1997, 117 patients underwent 118 HTs; 71 patients (15 women and 56 men) had 72 HTs by standard technique and 46 patients (9 women, 37 men) underwent HT using bicaval procedures. Preoperative parameters were similar in both groups; 5 patients who underwent the standard technique and no patients who underwent bicaval procedures required permanent pacemakers (p = NS). Isoproterenol infusion was significantly longer in the standard technique. Major perioperative arrhythmias (ventricular tachycardia and fibrillation, asystole) appeared in 8.2% and 7.0% of standard and bicaval HTs, respectively; atrial fibrillation appeared in 13.1% and 4.6%, respectively (p = NS). At 1 month, mitral and tricuspid regurgitation rates were higher in the standard group (p = NS); at 1 year only tricuspid regurgitation was still higher (p = NS). Right atrial pressure, Wood units, cardiac output, and cardiac index were examined (p = NS). At multivariate analysis, interaction between preoperative Wood units and transplant type was elicited for Wood units at 1 month and for right atrial pressure at 1, 3, and 6 months. In the high resistance subgroup, the patients who underwent bicaval procedures had higher resistances at 1 month. In the low resistance subgroup, right atrial pressure was higher in patients who underwent standard techniques at 1, 3, and 6 months follow-up. Thus, bicaval HT was found to be safe, without surgically related complications, it provoked significantly less blood loss, and required less isoproterenol use. No significant advantages were observed in conduction disturbances and major arrhythmias or regarding the need for temporary or permanent pacemakers.
Article
Performing a precise inferior vena caval (IVC) anastomosis during bicaval orthotopic heart transplantation can sometimes be challenging because of crowding of the operative field by the venous cannula and tourniquet. We performed bicaval orthotopic heart transplantation in 10 patients using an open IVC anastomotic technique with vacuum-assisted venous drainage. A long venous cannula was passed into the IVC through the femoral vein. The IVC anastomosis was performed after removing the IVC tourniquet under vacuum-assisted venous drainage. A precise edge-to-edge IVC anastomosis was successfully performed in all patients. This technique may result in greater anastomotic precision and improved outcomes.
Article
Cardiac transplantation provides definitive therapy for selected patients with end-stage congestive heart failure and has resulted in improved survival for these patients. Cardiac transplantation has also been associated with improving survival during the past two decades since it re-emerged as an
Article
This study investigates the outcomes of cardiac transplantation using older donors. Despite high mortality rates on waiting lists, transplanting hearts from older donors remains a relative contraindication. We retrospectively reviewed data on 479 adult heart transplant recipients, 352 status I patients, and 534 status II patients enrolled on a waiting list between 1992 and 1999. The Cox proportional hazards model was used for statistical analysis. Of all donors, 20% were 40 to 50 years old and 8% were > or =50 years old. The risk of six-month mortality on the waiting list for patients who were not transplanted (status I: relative risk [RR] 8.5; status II: RR 3.7) significantly outweighed the risk of transplanting patients with a heart from donors >40 years old (status I: RR 1.6; status II: RR 2.1). Recipients of cardiac allografts from donors <40 years old had a one-month mortality rate of 5%, in contrast to 13% and 22% in those receiving allografts from donors 40 to 50 years old and > or =50 years old, respectively. Donor age did not influence long-term survival or frequency of rejections; however, it did correlate with the early presence of transplant-related coronary artery disease (TCAD). By the first annual angiogram, only 17% of recipients with donors <20 years old developed TCAD, in contrast to 26% to 30% and 34% of recipients who received allografts from donors age 20 to 40 years and >40 years, respectively. Despite a strong association between older donor age and increased post-operative mortality and TCAD, it is more beneficial in terms of patient survival to receive an allograft from a donor >40 years old than to remain on the waiting list.
Article
The purpose of this study was to investigate whether broadening acceptance criteria for donor hearts and changing recipient demographics resulted in an increased perioperative morbidity and mortality in a heart transplant program. Donor and recipient data of 137 consecutive heart transplants performed from 1987 to 2001 were retrospectively analyzed and divided into three equal eras, each of 5 years: 1987 to 1991, 1992 to 1996, and 1997 to 2001. Multivariate analyses of recipient and donor demographics and operative factors were performed to identify the predictors of low cardiac output, intraaortic balloon pump utilization, 30-day mortality, and duration of intensive care and hospital stay. Significant increases in number of female recipients (p = 0.025), cardiopulmonary bypass (p < 0.001), recipient cross-clamp (p < 0.001), donor age (p = 0.009), donor ischemic times (p < 0.001), use of cardioplegia (p < 0.001) and the bicaval technique (p < 0.001), brain death to retrieval time (p = 0.006), and need for postoperative dialysis were observed for the three study periods, whereas length of intensive care and hospital stay decreased. Female donor (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.0 to 5.7) was identified as a risk factor for low cardiac output. Female donor (OR, 3.7; 95% CI, 1.3 to 10.7), donor cardiac arrest (OR, 6.4; 95% CI, 1.6 to 25.9), and cardiopulmonary bypass time more than 2 hours (OR, 7.6; 95% CI, 2.1 to 28.1) were associated with increased intraaortic balloon pump utilization. Intensive care stay was prolonged by the biatrial technique (OR, 3.9; 95% CI, 1.3 to 11.9) and reduced by the use of cardioplegia (OR, 0.3; 95% CI, 0.1 to 0.9), longer cardiopulmonary bypass (OR, 0.2; 95% CI, 0.1 to 0.6) and aortic cross-clamp times (OR, 0.1; 95% CI, 0.03 to 0.6). Although a number of significant changes were observed during the study period, no donor, recipient, or operative factors influenced 30-day mortality. This study justifies our current donor and recipient selection policies.
Article
After heart transplantation the effect of immunosuppression is monitored by histopathology of endomyocardial biopsy (EMB). EMB is usually carried out under X-ray guidance. Between January 1998 and March 2003, 1,262 biopsies were collected under echo-guidance in 156 patients. The biopsy access was gained through the internal jugular vein, by the standard catheterization technique. The average time of the procedure was 17 min. Four or five specimens were obtained from each patient, with a success rate of 96%. Complications involved two episodes of partial pneumothorax in one patient, atrial flutter in another and ventricular fibrillation in three patients. Conversion from echo to X-ray guidance was indicated in 11 patients. No case of significant tricuspid regurgitation related to the EMB procedure was recorded. The echo-guided endomyocardial biopsy appears to be a prospective alternative to the conventional approach under X-ray guidance. Its duration is comparable, it eliminates X-ray exposure, enables continuous echocardiographic monitoring and can be performed at the bedside.
Article
We herein report about 2 heart transplant patients undergoing surgical resection for esophageal cancer. Both were long-term survivors after orthotopic heart transplantation for dilated cardiomyopathy. One patient underwent a transthoracic esophagectomy and gastric pull-up for an early squamous cell carcinoma of the infracarinal esophagus. The second patient underwent a resection of the cervical esophagus and interposition of a free jejunal segment after neoadjuvant radiochemotherapy for a locally advanced squamous cell carcinoma in the cervical esophagus.
ResearchGate has not been able to resolve any references for this publication.